Daniel Pietrasz Selected Research

Daniel Pietrasz Research Topics

12	Adenocarcinoma 10/2022 - 07/2015
9	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 11/2016
4	Neoplasms (Cancer) 01/2020 - 11/2016
2	Carcinogenesis 01/2022 - 01/2016
2	Residual Neoplasm 01/2022 - 07/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 03/2024
1	Thrombosis (Thrombus) 01/2022
1	Brain Death (Brain Dead) 01/2022
1	Ascites 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Pathologic Complete Response 11/2019
1	Fatty Liver 01/2019
1	Pancreatic Fistula (Pancreatic Fistulas) 07/2015
1	Anastomotic Leak 07/2015
1	Sarcopenia 06/2015

9	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2016
6	folfirinoxIBA 03/2023 - 12/2015
6	Circulating Tumor DNAIBA 10/2022 - 11/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2024
1	CarbohydratesIBA 01/2022
1	AntigensIBA 01/2022
1	ABO Blood-Group SystemIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 11/2019
1	Pancreatitis-Associated ProteinsIBA 11/2017
1	Leucovorin (Folinic Acid)FDA Link 07/2017
1	Fluorouracil (Carac)FDA LinkGeneric 07/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2017
1	Thrombospondin 1IBA 11/2016
1	Cell-Free Nucleic AcidsIBA 11/2016
1	Annexin A6IBA 11/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2016
1	AnnexinsIBA 11/2016
1	AntibodiesIBA 01/2016

4	Liver Transplantation 03/2024 - 01/2019
3	Chemoradiotherapy 10/2022 - 07/2017
2	Drug Therapy (Chemotherapy) 03/2023 - 07/2017
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2022
1	Adjuvant Chemotherapy 12/2020
1	Pancreatectomy 08/2020
1	Radiotherapy 11/2019
1	Induction Chemotherapy 12/2015
1	Pancreaticojejunostomy 07/2015
1	Pancreaticoduodenectomy 07/2015
1	Hepatectomy 06/2015